Skip to main content

Published locations for JAK Inhibitor Ruxolitinib Wins First FDA Approval in Myelofibrosis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. JAK Inhibitor Ruxolitinib Wins First FDA Approval in Myelofibrosis

User login

  • Reset your password
  • /content/jak-inhibitor-ruxolitinib-wins-first-fda-approval-myelofibrosis
  • /edermatologynews/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /familypracticenews/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /ehospitalistnews/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /internalmedicinenews/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /rheumatologynews/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /oncologypractice/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /hematology-oncology/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /rheumatology/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval-myelofibrosis
  • /internalmedicine/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval
  • /dermatology/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval-myelofibrosis
  • /familymedicine/article/46386/oncology/jak-inhibitor-ruxolitinib-wins-first-fda-approval